Synapse - Guido Dalbagni

Results (33)

Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer

Journal Article

Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
JCO Precision Oncology (2024)

Fulltext@MSK | Save

Urethral melanoma - Clinical, pathological and molecular characteristics

Review

Mano, R.; Hoeh, B.; DiNatale, R. G.; Sanchez, A.; Benfante, N. E.; Reznik, E.; Leitao, M. M.; Shoushtari, A. N.; Goh, A.; Donat, S. M.; more...
Bladder Cancer (2022)

Fulltext@MSK | Save

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience

Meeting Abstract

Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer

Meeting Abstract

Walasek, A.; Almassi, N.; McPherson, V.; Dason, S.; Benfante, N.; Klein, T.; Berger, M. F.; Schultz, N.; Dalbagni, G.; Bajorin, D. F.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma

Meeting Abstract

Walasek, A.; Almassi, N.; Teo, M. Y.; Funt, S.; Schultz, N.; Dalbagni, G.; Hu, W.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Cancer susceptibility mutations in patients with urothelial malignancies

Journal Article

Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma

Meeting Abstract

Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma

Journal Article

Isharwal, S.; Audenet, F.; Drill, E.; Pietzak, E. J.; Iyer, G.; Ostrovnaya, I.; Cha, E.; Donahue, T.; Arcila, M.; Jayakumaran, G.; more...
European Urology Focus (2019)

Fulltext@MSK | Save

Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma

Journal Article

Audenet, F.; Isharwal, S.; Cha, E. K.; Donoghue, M. T. A.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Sfakianos, J. P.; Bagrodia, A.; Murugan, P.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy

Editorial

Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
European Urology (2019)

Fulltext@MSK | Save